Barbara Blodi

WRC Medical Director

MD, MALD

Early in her tenure as a UW faculty member, Dr. Blodi was the reading center PI for the seminal anti-VEGF trials for wet AMD (Marina and Anchor) and has recently published a conclusive study on macular atrophy in wet AMD (Ophthal Retina. 2023 Aug;7(8):661-671). In 2014, Dr. Blodi became the medical director of the WRC and has been involved in over 75 clinical trials including 9 NIH grants. Dr. Blodi serves on the Executive Committee of the DRCR Retina Network and has been the DRCR reading center PI for 11 trials. As a facilitator and impartial collaborator (she has no financial conflicts of interest), Dr. Blodi has been invited to participate in consensus groups such as CAM, the Mary Tyler Moore Vision Initiative, and the FDA Collaborative Community on Ophthalmic Imaging (CCOI); she is currently the AAO Subspecialty Day program chair. This year, Dr. Blodi was awarded the Macular Society’s Lawrence J. Singerman Medal for outstanding contributions to the advancement of science through retinal clinical trials. Dr. Blodi’s knowledge of clinical trials provides a vital bridge between the retina research community and industry stakeholders, facilitating invaluable communication within the field.